Venous thromboembolism in cancer: what is the optimal treatment? Strong evidence favors use of low molecular weight heparin to treat and prevent VTE in patients with cancer, but many clinicians have yet to modify their clinical practice

Venous thromboembolism (VTE) is a frequent complication in patients with cancer. Its occurrence worsens quality of life and adds to the management challenges for clinicians who treat these patients. The [...]